The Clayton Foundation for Research and its supporting entities currently conduct and fund medical research programs that apply to various indications, including:
- Cancer
- CNS
- Ophthalmology
- Metabolic diseases
- Infectious diseases
- Autoimmune and inflammation
- Women's health
- Cardiology
…and to different modalities:
- Cell and gene therapeutics
- Antibodies and biologics
- Small molecules
- Diagnostics
- Probiotics
- Medical devices
Current research include:
- Tumor targeting toxins
- Monoclonal antibody delivery systems
- Development of Novel Therapeutic Strategies for Hepatocellular Carcinoma
- Drug Delivery systems for treating solid tumors
- Engineered proteases and next generation protein therapeutics
- Fc engineered aglycosylated antibodies
- Bifunctional molecules for rapid protein clearance from blood
- Stem cell therapy for Parkinson's Disease
- New mechanisms and therapeutics for brain injury
- Gene and protein therapies for ocular diseases
- Early detection and treatment of glaucoma
- Optimization and Characterization of AAV for Gene Therapy
- Microbiome and treatment of metabolic diseases such as obesity
- Vaccines and diagnostics for Ehrlichioses
- Drug discovery program to host-based antiviral targets
- The Use of Light for Cardiological, Surgical and Related Purposes
- Electroceutical therapies for safe and targeted therapies
- Development of Artificial Neurotransmitter Systems
- Novel Biologically Active Peptides and Small Proteins (microproteins)
- The Morf Veuss Discovery, Screening, and Therapeutics Platform
- Identification of Functional Markers for Developing Side Effect-free Non-opioid Analgesics
